Page 16 - CASA Bulletin of Anesthesiology Vol 9 (4) 2022 (3)
P. 16

CASA Bulletin of Anesthesiology


                 Anesthetic implications in NF1 patients with an undiagnosed laryngeal

                                     plexiform neurofibroma: A case report


                                                         1
                                      1
                                                                                                     2
               Muhammad H. Yousef   MD, Xiaowei Lu   MD, Marci J. Neidich 2, Nancy M. Bauman  MD,
                                     3
                                                             1
               Brigitte C Widemann   MD,Andrew Mannes   MD.
               1  Department of Perioperative Medicine, the National Institutes of Health Clinical Center,
               Bethesda, MD.
               2  Division of Pediatric Otolaryngology, Children’s National Medical Center, Washington, DC.
               3  Pediatric Oncology Branch, NCI, NIH, Bethesda, MD.

               Correspondence: Andrew Mannes, Department of Perioperative Medicine. Bldg 10/2C-525. 10
               Center Dr Bethesda, MD 20892. (301) 545-7320, (301) 480-1699 (fax)

               Abstract


                   Neurofibromatosis is an autosomal dominant genetic disorder characterized by cutaneous
               café au lait spots, central and peripheral nervous system neurofibromas, and other tumors arising
               from the central nervous system.  Airway obstruction from pharyngeal or laryngeal involvement
               is rare, but when incidentally found, can cause great difficulty with airway management under
               anesthesia as illustrated in this case.

                   As part of a National Institutes of Health (NIH) Neurofibromatosis (NF) protocol study, a 3
               year old African American male enrolled in the NF Type 1 natural history protocol presented for
               an MRI under anesthesia to assess interval progression of the disease.   The patient was recently
               diagnosed with obstructive sleep apnea (OSA) presumed secondary to enlarged adenoids and an
               otolaryngology consultation was pending.  Pre-anesthesia evaluation performed by the Pre-
               Anesthesia Clinic Anesthesiologist was otherwise normal.

                   Initially, the magnetic resonance imaging study (MRI) was to be performed under
               Monitored Anesthesia Care/Sedation (MAC) with propofol infusion.  Due to difficulties
               maintaining adequate ventilation, even with the use of head positioning maneuvers,
               oropharyngeal and nasopharyngeal airways, and varying Laryngeal Mask Airways (LMA), this
               sedation case was emergently converted to general endotracheal anesthesia.  Direct laryngoscopy
               revealed a large submucosal mass in the right supraglottis that nearly completely obstructed the
               glottic inlet.  The patient was intubated and admitted to National Institutes of Health Clinical
               Center Intensive Care Unit (ICU) and later transferred to Children’s National Medical Center
               Pediatric ICU.  An Otolaryngology consultation was obtained for management of the obstructing
               laryngeal mass, presumed to be a plexiform neurofibroma. This case report highlights the need to
               recognize the rare occurrence of obstructing airway neurofibromas in patients with NF-1 to
               minimize the risk of airway obstruction under sedation and general anesthesia.




                                                                                            P a g e  15 | 65
   11   12   13   14   15   16   17   18   19   20   21